238 filings
ARS
2023 FY
CRSP
CRISPR Therapeutics AG
9 Apr 24
Annual report to shareholders
4:47pm
DEFA14A
CRSP
CRISPR Therapeutics AG
9 Apr 24
Additional proxy soliciting materials
4:43pm
DEF 14A
CRSP
CRISPR Therapeutics AG
Definitive proxy
9 Apr 24
4:42pm
PRE 14A
CRSP
CRISPR Therapeutics AG
Preliminary proxy
27 Mar 24
4:30pm
10-K
2023 FY
CRSP
CRISPR Therapeutics AG
Annual report
21 Feb 24
7:50am
8-K
3tmj1ct t1dz
21 Feb 24
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
7:45am
8-K
1n17om 73j5de1ri2in8
13 Feb 24
Entry into a Material Definitive Agreement
5:22pm
424B5
fv5vb33h5pe1y
13 Feb 24
Prospectus supplement for primary offering
8:44am
8-K
xm57kt1o6xny0y9ydx0
13 Feb 24
Other Events
6:30am
8-K
ssa2tlfyx2gx6zz1jk
16 Jan 24
Other Events
4:11pm
8-K
xmp 276k2
19 Dec 23
Departure of Directors or Certain Officers
4:23pm
8-K
rlykib7aunwlz3pqk8
15 Dec 23
Other Events
8:58am
8-K
lqv iyelrqoz12y
13 Dec 23
Entry into a Material Definitive Agreement
9:22am
8-K
sah63u5i54kh
8 Dec 23
Other Events
1:16pm
8-K
6ruy57 6y1hi3
4 Dec 23
Other Events
4:26pm
8-K
xuy6mmy33a5rs
16 Nov 23
Other Events
7:21am
8-K
vsjzx67 ilxmm
6 Nov 23
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
4:33pm
8-K
5himg
7 Sep 23
CRISPR Therapeutics Announces Leadership Transition
8:39am
S-8
t95oh f28h
7 Aug 23
Registration of securities for employees
4:18pm